Celemics

Celemics Inventory

The Inventory of Celemics (331920.KQ) as of Nov 13, 2026 is 1.47 B KRW. In the previous year, Inventory was 1.10 B KRW — a change of 33.60% (higher).

Inventory

1.47 BKRW

YoY

33.60%

Last updated:

Inventory of Celemics is 2025 1.47 B KRW. Inventory of Celemics was 2024 1.10 B KRW. It decreases by 33.60% higher compared to the previous year.

The Celemics Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
550.96 M KRW
Jan 1, 2019
444.36 M KRW
Jan 1, 2020
773.83 M KRW
Jan 1, 2021
679.48 M KRW
Jan 1, 2022
1.39 B KRW
Jan 1, 2023
942.63 M KRW
Jan 1, 2024
1.10 B KRW
Jan 1, 2025
1.47 B KRW
The Celemics Inventory history
YEARInventoryYoY
1.47 BKRW+33.60%
1.10 BKRW+16.39%
942.63 MKRW-31.98%
1.39 BKRW+103.95%
679.48 MKRW-12.19%
773.83 MKRW+74.15%
444.36 MKRW-19.35%
550.96 MKRW+63.89%
336.18 MKRW+16.26%
289.15 MKRW-12.37%
329.97 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celemics stock

Inventory of Celemics is 1.47 B KRW in 2025.

Inventory of Celemics changed from 1.10 B KRW to 1.47 B KRW, representing a 33.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Celemics since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Celemics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Celemics

All Key Metrics — Celemics